Molecular Biomarkers in Cancer

Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer, occurrence of cancer, or patient outcome. They may include somatic genetic variants, epigenetic signatures, transcriptional changes and proteomic signatures. These indicators are based on biomolecules, such as nucleic acids and proteins, that can be detected in samples obtained from tissues through tumor biopsy or, more easily and non-invasively, from blood, saliva.

  • Biomolecules
  • Detection technologies
  • Clinical applications of biomarkers
  • Diagnosis and prognosis of Cancer
  • Cancer Medicine

Related Conference of Molecular Biomarkers in Cancer

October 04-05, 2023

8th Global Summit on Cancer Science and Oncology

Barcelona, Spain
November 08-09, 2023

International Conference on Cancer Biology and Therapeutics

Budapest, Hungary
November 15-16, 2023

36th Conference on Preventive Oncology and Diagnostic Cancer

Edinburgh, Scotland
December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Molecular Biomarkers in Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in